US Stem Cell Inc (USRM)

[InvestorStemCell]

10K thoughts/late to the party. below IMO is the highlights. I smell a financing deal. Look for it to take place PRIOR to the ASHER warrants being born...

Like most I was expecting revenue and plenty of it. Like most I saw a trading pattern that in the past 3 plus years I had not seen prior and surmised that only revenue could stop dilution.

Well below is " why " IMO of the trading pattern has changed. CSC is a "rain maker" do a search on them and they come up in a lot of equity deals and an on small tech's. If anyone knows whom ASHER is, they facilitate most of the bridge loans for Companies looking to find investment monies. They now have 50m shares in warrants that expire TEN years from now at 3-11 cents.

Cassel Salpeter & Co. is an independent investment banking firm that provides advice to middle-market and emerging growth companies in the U.S. and worldwide. Together, the firm’s professionals have more than 50 years of experience providing private and public companies with a broad spectrum of investment banking and financial advisory services, including: mergers and acquisitions; equity and debt capital raises; fairness and solvency opinions; valuations; and restructurings, such as 363 sales and plans of reorganization. Co-founded by James Cassel and Scott Salpeter, the firm provides objective, unbiased, results-focused services that clients need to achieve their goals. Personally involved at every stage of all engagements, the firm’s senior partners have forged relationships and completed hundreds of transactions and assignments nationwide. The firm’s headquarters are in Miami.

Recent Sales of Unregistered Securities

below is ASHER

In 2013, the Company sold an aggregate of 50,029,227 shares of the Company’s common stock and warrants to purchase 50,350,536 shares of the Company’s common stock for aggregate gross cash proceeds of $865,000. The warrants are (i) exercisable solely for cash at an exercise price of ranging from $0.11 to $0.0299 per share, (ii) non-transferable for six months following issuance and (iii) exercisable, in whole or in part, at any time during the period commencing on the date that is six months and one day following the date of issuance and ending on the tenth year anniversary of the date of issuance.